vimarsana.com

Latest Breaking News On - Cordeliers research center - Page 1 : vimarsana.com

DNA/RNA Sequencing Aids Subsequent Treatment Selection in HCC/H-CCK Post Atezolizumab/Bevacizumab

Tissue- and blood-based molecular analysis could help match patients with advanced hepatocellular carcinoma or hepatocholangiocarcinoma following disease progression on frontline atezolizumab and bevacizumab to targeted therapy or another TKI based on identified genomic alterations.

Complement system could provide cancer prognostic biomarkers

Complement system could provide cancer prognostic biomarkers

Improving Clinical Research in Oncology Using Immune Scoring Biomarkers & a Multi-omics Approach, Upcoming Webinar Hosted by Xtalks

Lunaphore Technologies S A : Lunaphore Announces Formation of New Scientific Advisory Board

Lunaphore Technologies S.A.: Lunaphore Announces Formation of New Scientific Advisory Board Lunaphore Technologies SA, a Swiss life-sciences company developing innovative next-generation equipment for cancer research, announces the formation of its Scientific Advisory Board (SAB) with the appointment of two experts in the immuno-oncology (I-O) field to provide strategic advisory support to the company s R&D activities and product portfolio development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210114005435/en/ Dr. Jerome Galon Member of Lunaphore Scientific Advisory Board (Photo: Business Wire) The role of the SAB will be to bring strategic insights that will enable Lunaphore to become leaders in the field of high-dimensional analysis of tissue samples. The SAB will support as well in the establishment of scientific partnerships with key stakeholders for the coming years.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.